PATH

UiPath

$10.09

-7.35%
Apr 23, 2026
Bobby Quantitative Model
UiPath, Inc. is a leading provider of an end-to-end enterprise automation platform, operating in the Software - Infrastructure industry. The company is a pioneer and market leader in Robotic Process Automation (RPA), leveraging computer vision, AI, and APIs to automate repetitive tasks across various business functions and industries. The current investor narrative is intensely focused on the company's positioning in the age of generative AI, with debates centering on whether its RPA foundation is a durable competitive advantage or faces existential threat from more advanced AI agents, while recent financials show a path toward consistent profitability amidst this technological transition.

People also watch

Microsoft

Microsoft

MSFT

Analysis
Oracle Corporation

Oracle Corporation

ORCL

Analysis
Palantir Technologies

Palantir Technologies

PLTR

Analysis
Palo Alto Networks

Palo Alto Networks

PANW

Analysis
CrowdStrike

CrowdStrike

CRWD

Analysis

PATH 12-Month Price Forecast

Historical Price
Current Price $10.09
Average Target $10.09
High Target $11.603499999999999
Low Target $8.5765

Wall Street consensus

Most Wall Street analysts maintain a constructive view on UiPath's 12-month outlook, with a consensus price target around $13.12 and implied upside of +30.0% versus the current price.

Average Target

$13.12

5 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

5

covering this stock

Price Range

$8 - $13

Analyst target range

Buy
1 (20%)
Hold
2 (40%)
Sell
2 (40%)

Analyst coverage for UiPath appears limited, with only 5 analysts providing estimates for future EPS and revenue, though a separate list shows 10 firms issuing ratings actions in March 2026. The consensus sentiment from recent institutional ratings is overwhelmingly neutral to bearish, with actions in March including 'Market Perform', 'Hold', 'Equal Weight', 'Neutral', and one 'Underperform' from B of A Securities; a single 'Buy' rating from Canaccord Genuity stands out as the lone bullish call. The average revenue estimate for the next period is $2.05 billion, with a tight range between $2.04B and $2.06B, indicating strong consensus on the top-line outlook. The lack of a published average price target in the data and the minimal number of analysts providing estimates suggest limited or fragmented coverage, which is atypical for a company of this market cap and can lead to higher volatility and less efficient price discovery as the stock is more influenced by retail sentiment and macroeconomic flows rather than deep fundamental analysis.

Drowning in data?

Find the real signal!

Bulls vs Bears: PATH Investment Factors

The evidence currently tilts bearish, driven by severe price underperformance, decelerating revenue growth, and a pervasive narrative of competitive disruption from generative AI. The bull case rests on a compelling valuation disconnect, strong profitability, and a strategic bet on the agentic AI transition. The single most important tension in the investment debate is whether UiPath's RPA foundation and enterprise footprint provide a durable competitive moat for the AI era, or if they represent legacy technology vulnerable to displacement. The resolution of this question will determine if the current valuation represents a deep value opportunity or a value trap.

Bullish

  • Strong Profitability & Cash Flow: UiPath has achieved robust profitability with a TTM net margin of 17.53% and generated $352.2 million in free cash flow, yielding a healthy 5.2% FCF yield. This provides a solid financial foundation and internal funding for its strategic pivot into agentic AI.
  • Attractive Forward Valuation: The stock trades at a forward P/E of 11.6x, which is a significant discount to its trailing P/E of 24.0x and implies the market expects near-doubling of earnings. This forward multiple appears reasonable for a software company with 13.6% revenue growth and expanding margins.
  • Robust Balance Sheet: The company has a fortress balance sheet with a strong current ratio of 2.48 and minimal debt, evidenced by a debt-to-equity ratio of just 0.034. This financial strength provides resilience against market volatility and funds strategic investments without dilution.
  • High Gross Margins: UiPath maintains exceptional gross margins of 82.98%, indicative of a highly scalable software platform with low incremental costs. This provides significant operating leverage as the company grows its revenue base.

Bearish

  • Severe Revenue Deceleration: Q4 revenue growth decelerated to 13.56% YoY from 19.4% in the prior-year quarter. This slowing top-line momentum, amidst the AI investment boom, raises fundamental questions about competitive durability and market demand for its core RPA offerings.
  • Extreme Technical Downtrend: The stock is in a pronounced downtrend, down 32.58% over six months and 27.41% over three months, underperforming the S&P 500 by 23.75% in the last month alone. Trading near its 52-week low of $9.28 reflects intense, company-specific selling pressure and negative sentiment.
  • Existential Competitive Threat: The core bear narrative centers on generative AI and advanced AI agents posing an existential threat to traditional RPA. News snippets explicitly warn that this competition 'could permanently impair its growth trajectory,' creating a significant overhang on the stock.
  • Weak Analyst Sentiment: Recent institutional ratings are overwhelmingly neutral to bearish, with actions including 'Market Perform', 'Hold', 'Equal Weight', 'Neutral', and one 'Underperform'. The lack of a clear average price target suggests limited conviction and fragmented coverage.

PATH Technical Analysis

The prevailing price trend is a pronounced and sustained downtrend, with the stock down 32.58% over the last six months and 27.41% over the last three months. With a current price of $10.41, the stock is trading near the bottom of its 52-week range, at approximately 52.5% of the distance between its 52-week low of $9.28 and high of $19.84, indicating it is in deep value territory but also reflects significant negative momentum and investor pessimism. Recent momentum shows severe underperformance, with the stock down 16.39% over the past month, starkly contrasting with the S&P 500's gain of 7.36% over the same period, resulting in a massive negative relative strength of -23.75; this divergence signals intense, company-specific selling pressure rather than a broad market move. Key technical support is clearly defined at the 52-week low of $9.28, while resistance lies at the 52-week high of $19.84; a sustained breakdown below $9.28 would signal a complete loss of the prior trading range and likely trigger further selling, whereas a recovery above the recent breakdown levels near $12-13 is needed to suggest stabilization. The stock's beta of 1.025 indicates volatility roughly in line with the broader market, but its recent price action, including a maximum drawdown of -51.37%, reveals it has experienced idiosyncratic, high-magnitude downside risk independent of market movements.

Beta

1.02

1.02x market volatility

Max Drawdown

-51.4%

Largest decline past year

52-Week Range

$9-$20

Price range past year

Annual Return

-7.2%

Cumulative gain past year

PeriodPATH ReturnS&P 500
1m-8.9%+8.5%
3m-31.8%+2.8%
6m-38.8%+4.6%
1y-7.2%+32.3%
ytd-36.5%+3.9%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

PATH Fundamental Analysis

Revenue growth has been positive but shows signs of deceleration from prior highs; the most recent quarterly revenue (Q4 FY26 ending Jan 31, 2026) was $481.1 million, representing a year-over-year growth of 13.56%, which is a deceleration from the 19.4% YoY growth seen in the prior-year Q4. Segment data shows the business is primarily driven by Subscription Services ($251.2M) and License revenue ($215.9M), with Professional Services being a minor contributor ($31.6M). The company has achieved profitability on a trailing twelve-month basis, with a net margin of 17.53% and a quarterly net income of $104.5 million in its latest quarter. Gross margins remain exceptionally strong at 82.98%, but operating margins are thin at 3.78%, indicating high operating expenses; however, the trend is improving, as the latest quarter's operating income of $80.3 million and operating margin of 16.68% show a significant expansion from the operating loss in the year-ago period. The balance sheet is robust with a strong liquidity position, evidenced by a current ratio of 2.48 and minimal debt, with a debt-to-equity ratio of just 0.034. The company is generating substantial free cash flow, with TTM free cash flow of $352.2 million, providing ample internal funding for growth and yielding a healthy FCF yield of approximately 5.2% based on the current market cap; return on equity is a solid 13.56%, indicating efficient use of shareholder capital.

Quarterly Revenue

$481107000.0B

2026-01

Revenue YoY Growth

+0.13%

YoY Comparison

Gross Margin

+0.84%

Latest Quarter

Free Cash Flow

$352160000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Open an Account, get $2 TSLA now!

Valuation Analysis: Is PATH Overvalued?

Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 24.0x, while the forward PE (based on estimated EPS) is significantly lower at 11.6x. This substantial gap implies the market is pricing in a significant earnings growth acceleration, with forward earnings estimates nearly double the trailing figure. Compared to industry averages, the trailing PE of 24.0x is difficult to contextualize without a specific sector average, but the forward PE of 11.6x appears reasonable for a software company with mid-teens revenue growth and expanding profitability. The stock's current Price-to-Sales ratio of 4.21x and EV/Sales of 2.59x provide additional context, suggesting the market is valuing the company at a moderate multiple of its revenue base. Historically, the stock's own valuation has compressed dramatically; its current trailing PE of 24.0x is near the lower end of its historical range observed in recent quarters, which has seen figures as high as 994x during periods of minimal earnings and as low as 10.7x. Trading near the bottom of its own historical valuation band suggests the market is pricing in significant skepticism about future growth, potentially presenting a value opportunity if the company can execute on its agentic AI transition and sustain profitability.

PE

24.0x

Latest Quarter

vs. Historical

Low-End

5-Year PE Range -163x~994x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

76.7x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: The primary financial risk is revenue growth deceleration, which fell to 13.56% YoY in Q4 from 19.4% a year prior. If this trend continues, it will pressure the forward P/E multiple of 11.6x, which is predicated on earnings growth acceleration. While the balance sheet is strong, the thin operating margin of 3.78% indicates high operating expenses; a failure to leverage these costs as revenue grows could stall profitability improvements. Furthermore, the company's valuation is highly sensitive to its growth narrative, making it vulnerable to any earnings miss or guidance reduction.

Market & Competitive Risks: The most severe external risk is technological disruption from generative AI and autonomous agents, which threatens the core RPA value proposition. The stock's massive underperformance (-23.75% vs. S&P 500 over one month) signals the market is pricing in this existential threat. Valuation compression is a clear risk, as the stock trades near the bottom of its own historical P/E range. With a beta of 1.025, it has market-like volatility but has demonstrated idiosyncratic downside, with a maximum drawdown of -51.37%. The overwhelmingly neutral-to-bearish analyst sentiment further exacerbates the lack of positive catalysts.

Worst-Case Scenario: The worst-case scenario involves a confirmation of the competitive threat, leading to a rapid erosion of UiPath's market share, a collapse in revenue growth to low single digits, and multiple compression. This could trigger a wave of analyst downgrades and a breach of the key technical support at the 52-week low of $9.28. In this adverse scenario, the stock could realistically re-test its 52-week low, implying a downside of approximately -11% from the current price of $10.41. A more severe bear case, factoring in a loss of confidence in the business model, could see the stock fall 30-40% from current levels, mirroring its historical max drawdown magnitude.